Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · IEX Real-Time Price · USD
14.90
+0.35 (2.41%)
At close: Mar 28, 2024, 4:00 PM
15.20
+0.30 (2.01%)
After-hours: Mar 28, 2024, 7:16 PM EDT

Pliant Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Cash & Equivalents
64.7233.6951.6750.8885.8160.95
Short-Term Investments
431.01297.5148.93226.0116.970
Cash & Cash Equivalents
495.73331.19200.6276.89102.7760.95
Cash Growth
49.68%65.10%-27.55%169.42%68.62%-
Receivables
01.9829.287.050
Other Current Assets
9.787.146.854.582.080.78
Total Current Assets
505.5340.31209.44290.75111.961.73
Property, Plant & Equipment
4.789.9110.944.324.084.26
Other Long-Term Assets
1.870.390.840.453.090.54
Total Long-Term Assets
6.6510.311.774.777.164.8
Total Assets
512.15350.61221.22295.53119.0666.53
Accounts Payable
4.531.582.972.021.252.58
Current Debt
1.322.461.87000
Other Current Liabilities
22.6819.8811.999.586.922.51
Total Current Liabilities
28.5223.9116.8311.68.175.08
Long-Term Debt
10.0513.365.33000
Other Long-Term Liabilities
0000.870.910.81
Total Long-Term Liabilities
10.0513.365.330.870.910.81
Total Liabilities
38.5837.2722.1612.479.085.9
Total Debt
11.3715.827.19000
Debt Growth
-28.09%119.84%----
Retained Earnings
-499.75-338.41-215.09-117.83-76.3-71.47
Comprehensive Income
0.35-1.96-0.2-0.03-00
Shareholders' Equity
473.58313.34199.06283.06-76.3-71.47
Net Cash / Debt
484.36315.37193.4276.89102.7760.95
Net Cash / Debt Growth
53.58%63.07%-30.15%169.42%68.62%-
Net Cash Per Share
8.257.515.4012.9763.3152.30
Working Capital
476.98316.4192.61279.16103.7356.65
Book Value Per Share
8.067.465.5513.26-47.00-61.32
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).